The U.S. Congress is pushing a wave of bills aimed at reducing economic ties with China — but critics say these moves could hurt America more than help. From biotech to drones, here's why experts call it a 'self-sabotage' strategy.
Cancer Research Caught in Crossfire
A proposed bill targets five Chinese biotech firms, banning them from working with federally funded U.S. entities. These companies help American doctors identify cancer-causing genes and manufacture lifesaving drugs. 'Disrupting these partnerships could delay clinical trials and raise drug costs,' industry leaders warn. Imagine halting cancer breakthroughs over politics.
Grounding DJI Drones: Security or Overreach?
Another bill seeks to ban drones by China's DJI — which controls 70% of the global market — citing 'national security risks.' Critics argue the move could spike costs for U.S. farmers, firefighters, and filmmakers who rely on DJI's affordable tech. 'Where’s the evidence?' ask privacy advocates, while Rep. Elise Stefanik insists it's about 'protecting data.'
The Cost of Economic 'Self-Goals'
The 45-year U.S.-China Science and Tech Agreement now hangs in limbo, threatening joint climate and AI research. 'Decoupling isn’t a strategy — it’s a lose-lose,' says analyst William Jones. With bills risking supply chains and innovation, young entrepreneurs and researchers fear collateral damage. Could America’s tech race turn into a stumble?
As tensions rise, one question lingers: In a connected world, can any nation truly go it alone?
Reference(s):
U.S. Congress attempts to 'decouple' from China will be an own goal
cgtn.com